Corporate Announcements

Subject Announcement Attachment
Clarification- Financial Results MADHAVBAUG : The Exchange has sought clarification from Vaidya Sane Ayurved Laboratories Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited. -
Newspaper Advertisements Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Financial Results published in Newspaper- Financial Express and Navshakti dated 05th May 2022
General updates Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Statement of Deviation or Variation in usage of funds raised through public issue pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Financial Result Updates Vaidya Sane Ayurved Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.
Press Release Vaidya Sane Ayurved Laboratories Limited has submitted the Exchange press release dated 04-May-2022 titled Press Release-March 2022
Outcome of Board Meeting Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Board of Directors in its Meeting held on 04-May-2022 considered and approved financial statements for the period ended March 2022 and Other business matters
Newspaper Advertisements Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Newspaper Advertisements-Media Coverage- Samyojanam 2022- National Ayurveda Youth Conclave
General updates Vaidya Sane Ayurved Laboratories Limited has submitted Exchange Compliance Certificate under regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
General updates Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March 2022
General updates Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Non-Applicability of Corporate Governance report under Regulation 27 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
General updates Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Compliance Certificate under Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
General updates Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulation, 2018
Disclosure under SEBI Takeover Regulations Promoter/Promoter Group of Vaidya Sane Ayurved Laboratories Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Disclosure under SEBI Takeover Regulations Promoter/Promoter Group of Vaidya Sane Ayurved Laboratories Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Disclosure under SEBI Takeover Regulations Promoter/Promoter Group of Vaidya Sane Ayurved Laboratories Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022
Closure of trading window Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Closure of trading window